<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39102426</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure.</ArticleTitle><Pagination><StartPage>e1012291</StartPage><MedlinePgn>e1012291</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012291</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1012291</ELocationID><Abstract><AbstractText>SARS-CoV-2 spike protein (SARS-2-S) induced cell-cell fusion in uninfected cells may occur in long COVID-19 syndrome, as circulating SARS-2-S or extracellular vesicles containing SARS-2-S (S-EVs) were found to be prevalent in post-acute sequelae of COVID-19 (PASC) for up to 12 months after diagnosis. Although isolated recombinant SARS-2-S protein has been shown to increase the SASP in senescent ACE2-expressing cells, the direct linkage of SARS-2-S syncytia with senescence in the absence of virus infection and the degree to which SARS-2-S syncytia affect pathology in the setting of cardiac dysfunction are unknown. Here, we found that the senescent outcome of SARS-2-S induced syncytia exacerbated heart failure progression. We first demonstrated that syncytium formation in cells expressing SARS-2-S delivered by DNA plasmid or LNP-mRNA exhibits a senescence-like phenotype. Extracellular vesicles containing SARS-2-S (S-EVs) also confer a potent ability to form senescent syncytia without de novo synthesis of SARS-2-S. However, it is important to note that currently approved COVID-19 mRNA vaccines do not induce syncytium formation or cellular senescence. Mechanistically, SARS-2-S syncytia provoke the formation of functional MAVS aggregates, which regulate the senescence fate of SARS-2-S syncytia by TNF&#x3b1;. We further demonstrate that senescent SARS-2-S syncytia exhibit shrinked morphology, leading to the activation of WNK1 and impaired cardiac metabolism. In pre-existing heart failure mice, the WNK1 inhibitor WNK463, anti-syncytial drug niclosamide, and senolytic dasatinib protect the heart from exacerbated heart failure triggered by SARS-2-S. Our findings thus suggest a potential mechanism for COVID-19-mediated cardiac pathology and recommend the application of WNK1 inhibitor for therapy especially in individuals with post-acute sequelae of COVID-19.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huilong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Basic Medical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Luming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Muyi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Enhao</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Linfei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yilong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qihong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingfei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Bingqing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Yaogen Biotechnology Co.Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xufeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Yaogen Biotechnology Co.Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Sichong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Xuejing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pathology, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ruzhou</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaopan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shipo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Yaogen Biotechnology Co.Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Gong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Gengye</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Beijing Yaogen Biotechnology Co.Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Lihua</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Basic Medical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Congwen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Hui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2128-9686</Identifier><AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015726" MajorTopicYN="Y">Giant Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016922" MajorTopicYN="Y">Cellular Senescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="N">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39102426</ArticleId><ArticleId IdType="pmc">PMC11326701</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1012291</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-23-01794</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paci E, Bisanti L. [The COVID-19 epidemic and total mortality: missed data and the incoming epidemiology]. Epidemiol Prev. 2023;47(1&#x2013;2):67&#x2013;72. Epub 2023/04/20. doi: 10.19191/EP23.1-2.A571.023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.19191/EP23.1-2.A571.023</ArticleId><ArticleId IdType="pubmed">37078199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, Force RMPT. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12. Epub 2023/03/23. doi: 10.7554/eLife.86002 ; PubMed Central PMCID: PMC10032659.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. 2022;4(1):90. Epub 2022/04/12. doi: 10.1007/s42399-022-01167-4 ; PubMed Central PMCID: PMC8977184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId><ArticleId IdType="pmc">PMC8977184</ArticleId><ArticleId IdType="pubmed">35402784</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. Epub 2021/07/13. doi: 10.3389/fmicb.2021.698169 ; PubMed Central PMCID: PMC8260991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Xanthopoulos A, Bourazana A, Giamouzis G, Skoularigki E, Dimos A, Zagouras A, et al.. COVID-19 and the heart. World J Clin Cases. 2022;10(28):9970&#x2013;84. Epub 2022/10/18. doi: 10.12998/wjcc.v10.i28.9970 ; PubMed Central PMCID: PMC9561576.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i28.9970</ArticleId><ArticleId IdType="pmc">PMC9561576</ArticleId><ArticleId IdType="pubmed">36246800</ArticleId></ArticleIdList></Reference><Reference><Citation>Elseidy SA, Awad AK, Vorla M, Fatima A, Elbadawy MA, Mandal D, et al.. Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS). Int J Cardiol Heart Vasc. 2022;40:101012. Epub 2022/04/01. doi: 10.1016/j.ijcha.2022.101012 ; PubMed Central PMCID: PMC8958273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101012</ArticleId><ArticleId IdType="pmc">PMC8958273</ArticleId><ArticleId IdType="pubmed">35355927</ArticleId></ArticleIdList></Reference><Reference><Citation>John KJ, Mishra AK, Ramasamy C, George AA, Selvaraj V, Lal A. Heart failure in COVID-19 patients: Critical care experience. World J Virol. 2022;11(1):1&#x2013;19. Epub 2022/02/05. doi: 10.5501/wjv.v11.i1.1 ; PubMed Central PMCID: PMC8788216.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i1.1</ArticleId><ArticleId IdType="pmc">PMC8788216</ArticleId><ArticleId IdType="pubmed">35117968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariri E, Patel NG, Bassil E, Matta M, Yu PC, Pack QR, et al.. Acute but not chronic heart failure is associated with higher mortality among patients hospitalized with pneumonia: An analysis of a nationwide database(&#x2606;). Am J Med Open. 2022;7:100013. Epub 2022/06/24. doi: 10.1016/j.ajmo.2022.100013 ; PubMed Central PMCID: PMC9211036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajmo.2022.100013</ArticleId><ArticleId IdType="pmc">PMC9211036</ArticleId><ArticleId IdType="pubmed">35734378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar Y, Ullah W, Rauf H, Virk HUH, Yadav S, Chowdhury M, et al.. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. Int J Cardiol Heart Vasc. 2020;29:100589. Epub 2020/07/30. doi: 10.1016/j.ijcha.2020.100589 ; PubMed Central PMCID: PMC7359794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100589</ArticleId><ArticleId IdType="pmc">PMC7359794</ArticleId><ArticleId IdType="pubmed">32724831</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveiros A, Noyce RS, Gheblawi M, Colombo D, Bilawchuk LM, Clemente-Casares X, et al.. SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters. Am J Physiol Heart Circ Physiol. 2022;323(6):H1262&#x2013;H9. Epub 2022/11/12. doi: 10.1152/ajpheart.00578.2022 ; PubMed Central PMCID: PMC9705018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00578.2022</ArticleId><ArticleId IdType="pmc">PMC9705018</ArticleId><ArticleId IdType="pubmed">36367689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wei Z, Xiong C, Qian H. Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update. Virol J. 2022;19(1):108. Epub 2022/06/26. doi: 10.1186/s12985-022-01833-y ; PubMed Central PMCID: PMC9233758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01833-y</ArticleId><ArticleId IdType="pmc">PMC9233758</ArticleId><ArticleId IdType="pubmed">35752810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah MM, Bernier A, Buchrieser J, Schwartz O. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. J Mol Biol. 2022;434(6):167280. Epub 2021/10/05. doi: 10.1016/j.jmb.2021.167280 ; PubMed Central PMCID: PMC8485708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167280</ArticleId><ArticleId IdType="pmc">PMC8485708</ArticleId><ArticleId IdType="pubmed">34606831</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, et al.. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2020;39(23):e106267. Epub 2020/10/15. doi: 10.15252/embj.2020106267 ; PubMed Central PMCID: PMC7646020.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106267</ArticleId><ArticleId IdType="pmc">PMC7646020</ArticleId><ArticleId IdType="pubmed">33051876</ArticleId></ArticleIdList></Reference><Reference><Citation>Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, et al.. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without. iScience. 2021;24(3):102170. Epub 2021/02/16. doi: 10.1016/j.isci.2021.102170 ; PubMed Central PMCID: PMC7871100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102170</ArticleId><ArticleId IdType="pmc">PMC7871100</ArticleId><ArticleId IdType="pubmed">33585805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratt MA, Gallaher WR. Comparison of fusion from within and fusion from without by Newcastle disease virus. In Vitro. 1970;6(1):3&#x2013;14. Epub 1970/07/01. doi: 10.1007/BF02616129 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02616129</ArticleId><ArticleId IdType="pubmed">5535595</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer Z, Alhusaini N, Tabler CO, Sweet T, de Carvalho KIL, Schlatzer DM, et al.. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies. J Extracell Vesicles. 2021;10(8):e12112. Epub 2021/07/01. doi: 10.1002/jev2.12112 ; PubMed Central PMCID: PMC8213968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12112</ArticleId><ArticleId IdType="pmc">PMC8213968</ArticleId><ArticleId IdType="pubmed">34188786</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al.. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J Med Virol. 2023;95(2):e28568. Epub 2023/02/10. doi: 10.1002/jmv.28568 ; PubMed Central PMCID: PMC10048846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol. 2023;23(4):251&#x2013;63. Epub 2022/10/06. doi: 10.1038/s41577-022-00785-2 ; PubMed Central PMCID: PMC9533263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00785-2</ArticleId><ArticleId IdType="pmc">PMC9533263</ArticleId><ArticleId IdType="pubmed">36198912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al.. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599(7884):283&#x2013;9. Epub 2021/09/14. doi: 10.1038/s41586-021-03995-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J, d&#x2019;Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729&#x2013;40. Epub 2007/08/02. doi: 10.1038/nrm2233 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2233</ArticleId><ArticleId IdType="pubmed">17667954</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Micco R, Krizhanovsky V, Baker D, d&#x2019;Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22(2):75&#x2013;95. Epub 2020/12/18. doi: 10.1038/s41580-020-00314-w ; PubMed Central PMCID: PMC8344376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00314-w</ArticleId><ArticleId IdType="pmc">PMC8344376</ArticleId><ArticleId IdType="pubmed">33328614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari R, Jat P. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front Cell Dev Biol. 2021;9:645593. Epub 2021/04/16. doi: 10.3389/fcell.2021.645593 ; PubMed Central PMCID: PMC8039141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.645593</ArticleId><ArticleId IdType="pmc">PMC8039141</ArticleId><ArticleId IdType="pubmed">33855023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, et al.. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nature Aging. 2022;2(2):115&#x2013;24. doi: 10.1038/s43587-022-00170-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00170-7</ArticleId><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Pohlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020;78(4):779&#x2013;84 e5. Epub 2020/05/05. doi: 10.1016/j.molcel.2020.04.022 ; PubMed Central PMCID: PMC7194065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornich BF, Grosskopf AK, Schlagowski S, Tenbusch M, Kleine-Weber H, Neipel F, et al.. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation. J Virol. 2021;95(9). Epub 2021/02/21. doi: 10.1128/JVI.00002-21 ; PubMed Central PMCID: PMC8104116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00002-21</ArticleId><ArticleId IdType="pmc">PMC8104116</ArticleId><ArticleId IdType="pubmed">33608407</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al.. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022;603(7902):700&#x2013;5. Epub 2022/02/02. doi: 10.1038/s41586-022-04462-1 ; PubMed Central PMCID: PMC8942852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04462-1</ArticleId><ArticleId IdType="pmc">PMC8942852</ArticleId><ArticleId IdType="pubmed">35104835</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz SR, Dopfer-Jablonka A, et al.. Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75. Lancet Infect Dis. 2022;22(11):1537&#x2013;8. Epub 2022/09/19. doi: 10.1016/S1473-3099(22)00591-6 ; PubMed Central PMCID: PMC9477470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00591-6</ArticleId><ArticleId IdType="pmc">PMC9477470</ArticleId><ArticleId IdType="pubmed">36116462</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, et al.. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe. 2022;30(11):1540&#x2013;55 e15. Epub 2022/10/23. doi: 10.1016/j.chom.2022.10.003 ; PubMed Central PMCID: PMC9578327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9578327</ArticleId><ArticleId IdType="pubmed">36272413</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez Lopez YO, Casu A, Pratley RE. Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective. Front Immunol. 2021;12:617042. Epub 2021/05/11. doi: 10.3389/fimmu.2021.617042 ; PubMed Central PMCID: PMC8100059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.617042</ArticleId><ArticleId IdType="pmc">PMC8100059</ArticleId><ArticleId IdType="pubmed">33968019</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, et al.. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017;114(35):E7348&#x2013;E57. Epub 2017/08/16. doi: 10.1073/pnas.1707304114 ; PubMed Central PMCID: PMC5584442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1707304114</ArticleId><ArticleId IdType="pmc">PMC5584442</ArticleId><ArticleId IdType="pubmed">28807998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al.. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020;369(6510):1501&#x2013;5. Epub 2020/07/25. doi: 10.1126/science.abd0826 ; PubMed Central PMCID: PMC7402631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd0826</ArticleId><ArticleId IdType="pmc">PMC7402631</ArticleId><ArticleId IdType="pubmed">32703906</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wei L, Xu F, Zhao F, Huang Y, Fan Z, et al.. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response. Sci Signal. 2022;15(729):eabg8744. Epub 2022/04/13. doi: 10.1126/scisignal.abg8744 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abg8744</ArticleId><ArticleId IdType="pubmed">35412852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yeruva L, Marinov A, Prantner D, Wyrick PB, Lupashin V, et al.. The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection. J Immunol. 2014;193(5):2394&#x2013;404. Epub 2014/07/30. doi: 10.4049/jimmunol.1302718 ; PubMed Central PMCID: PMC4212656.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302718</ArticleId><ArticleId IdType="pmc">PMC4212656</ArticleId><ArticleId IdType="pubmed">25070851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol. 2020;20(9):537&#x2013;51. Epub 2020/03/24. doi: 10.1038/s41577-020-0288-3 ; PubMed Central PMCID: PMC7094958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y, Song T, Wei C, Ni C, Zheng Z, Xu Q, et al.. Negative regulation of MAVS-mediated innate immune response by PSMA7. J Immunol. 2009;183(7):4241&#x2013;8. Epub 2009/09/08. doi: 10.4049/jimmunol.0901646 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901646</ArticleId><ArticleId IdType="pubmed">19734229</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Yang S, Xing Y, Pan L, Zhao R, Zhao Y, et al.. Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target. Front Cell Dev Biol. 2021;9:673839. Epub 2021/07/27. doi: 10.3389/fcell.2021.673839 ; PubMed Central PMCID: PMC8293691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.673839</ArticleId><ArticleId IdType="pmc">PMC8293691</ArticleId><ArticleId IdType="pubmed">34307357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajant H, Siegmund D. TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages. Front Cell Dev Biol. 2019;7:91. Epub 2019/06/14. doi: 10.3389/fcell.2019.00091 ; PubMed Central PMCID: PMC6548990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00091</ArticleId><ArticleId IdType="pmc">PMC6548990</ArticleId><ArticleId IdType="pubmed">31192209</ArticleId></ArticleIdList></Reference><Reference><Citation>Naude PJ, den Boer JA, Luiten PG, Eisel UL. Tumor necrosis factor receptor cross-talk. FEBS J. 2011;278(6):888&#x2013;98. Epub 2011/01/15. doi: 10.1111/j.1742-4658.2011.08017.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2011.08017.x</ArticleId><ArticleId IdType="pubmed">21232019</ArticleId></ArticleIdList></Reference><Reference><Citation>Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott M. Tumour necrosis factor signalling in health and disease. F1000Res. 2019;8. Epub 2019/02/14. doi: 10.12688/f1000research.17023.1 ; PubMed Central PMCID: PMC6352924.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.17023.1</ArticleId><ArticleId IdType="pmc">PMC6352924</ArticleId><ArticleId IdType="pubmed">30755793</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128(4):1238&#x2013;46. Epub 2018/04/03. doi: 10.1172/JCI95148 ; PubMed Central PMCID: PMC5873888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI95148</ArticleId><ArticleId IdType="pmc">PMC5873888</ArticleId><ArticleId IdType="pubmed">29608137</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd-Shiwarski CR, Shiwarski DJ, Griffiths SE, Beacham RT, Norrell L, Morrison DE, et al.. WNK kinases sense molecular crowding and rescue cell volume via phase separation. Cell. 2022;185(24):4488&#x2013;506 e20. Epub 2022/11/02. doi: 10.1016/j.cell.2022.09.042 ; PubMed Central PMCID: PMC9699283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.042</ArticleId><ArticleId IdType="pmc">PMC9699283</ArticleId><ArticleId IdType="pubmed">36318922</ArticleId></ArticleIdList></Reference><Reference><Citation>Prisco SZ, Eklund M, Raveendran R, Thenappan T, Prins KW. With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension. JACC Basic Transl Sci. 2021;6(11):834&#x2013;50. Epub 2021/12/07. doi: 10.1016/j.jacbts.2021.09.004 ; PubMed Central PMCID: PMC8617575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8617575</ArticleId><ArticleId IdType="pubmed">34869947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, Ricci F, Gallina S, Di Baldassarre A, Ghinassi B. Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association. Int J Mol Sci. 2021;22(2). Epub 2021/01/14. doi: 10.3390/ijms22020614 ; PubMed Central PMCID: PMC7827742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020614</ArticleId><ArticleId IdType="pmc">PMC7827742</ArticleId><ArticleId IdType="pubmed">33435429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli J, Veenstra I, Demaria M. The struggle of a good friend getting old: cellular senescence in viral responses and therapy. EMBO Rep. 2021;22(4):e52243. Epub 2021/03/19. doi: 10.15252/embr.202052243 ; PubMed Central PMCID: PMC8024996.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202052243</ArticleId><ArticleId IdType="pmc">PMC8024996</ArticleId><ArticleId IdType="pubmed">33734564</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Zhao G, Li H. Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment. Front Immunol. 2017;8:1675. Epub 2017/12/14. doi: 10.3389/fimmu.2017.01675 ; PubMed Central PMCID: PMC5712345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01675</ArticleId><ArticleId IdType="pmc">PMC5712345</ArticleId><ArticleId IdType="pubmed">29234328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind P, Langsteger W, Koltringer P, Eber B, Kammerhuber F, Smolle-Juttner F, et al.. Localization of mediastinal parathyroid adenoma by T1-201 scintiscan and SPECT. Klin Wochenschr. 1990;68(9):472&#x2013;5. Epub 1990/05/04. doi: 10.1007/BF01648902 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01648902</ArticleId><ArticleId IdType="pubmed">2355726</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford). 2010;49(7):1215&#x2013;28. Epub 2010/03/03. doi: 10.1093/rheumatology/keq031 ; PubMed Central PMCID: PMC2886310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keq031</ArticleId><ArticleId IdType="pmc">PMC2886310</ArticleId><ArticleId IdType="pubmed">20194223</ArticleId></ArticleIdList></Reference><Reference><Citation>Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE. Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(10):2013&#x2013;21. Epub 2021/09/05. doi: 10.1007/s00210-021-02147-6 ; PubMed Central PMCID: PMC8417660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-021-02147-6</ArticleId><ArticleId IdType="pmc">PMC8417660</ArticleId><ArticleId IdType="pubmed">34480616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097&#x2013;100. Epub 2020/04/01. doi: 10.1093/cvr/cvaa078 ; PubMed Central PMCID: PMC7184507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusho T, Sohara E, Mandai S, Kikuchi H, Takahashi N, Fujimaru T, et al.. Renal TNFalpha activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease. Kidney Int. 2020;97(4):713&#x2013;27. Epub 2020/02/16. doi: 10.1016/j.kint.2019.11.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2019.11.021</ArticleId><ArticleId IdType="pubmed">32059997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mair J, Lindahl B, Hammarsten O, Muller C, Giannitsis E, Huber K, et al.. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7(6):553&#x2013;60. Epub 2017/12/28. doi: 10.1177/2048872617748553 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872617748553</ArticleId><ArticleId IdType="pubmed">29278915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wettersten N, Maisel A. Role of Cardiac Troponin Levels in Acute Heart Failure. Card Fail Rev. 2015;1(2):102&#x2013;6. Epub 2015/10/01. doi: 10.15420/cfr.2015.1.2.102 ; PubMed Central PMCID: PMC5491037.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/cfr.2015.1.2.102</ArticleId><ArticleId IdType="pmc">PMC5491037</ArticleId><ArticleId IdType="pubmed">28785441</ArticleId></ArticleIdList></Reference><Reference><Citation>Liuzzo G, Volpe M. SARS-CoV-2 infection markedly increases long-term cardiovascular risk. Eur Heart J. 2022;43(20):1899&#x2013;900. Epub 2022/04/02. doi: 10.1093/eurheartj/ehac168 ; PubMed Central PMCID: PMC9383629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac168</ArticleId><ArticleId IdType="pmc">PMC9383629</ArticleId><ArticleId IdType="pubmed">35362024</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Wang Y, Xi X, Jia Y, Tian J, Yu B, et al.. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm. Cardiovasc Drugs Ther. 2021;35(2):231&#x2013;47. Epub 2021/01/07. doi: 10.1007/s10557-020-07120-8 ; PubMed Central PMCID: PMC7786163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-020-07120-8</ArticleId><ArticleId IdType="pmc">PMC7786163</ArticleId><ArticleId IdType="pubmed">33404925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ickenstein LM, Garidel P. Lipid-based nanoparticle formulations for small molecules and RNA drugs. Expert Opin Drug Deliv. 2019;16(11):1205&#x2013;26. Epub 2019/09/19. doi: 10.1080/17425247.2019.1669558 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17425247.2019.1669558</ArticleId><ArticleId IdType="pubmed">31530041</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, et al.. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2010;51(3):836&#x2013;45. Epub 2009/12/31. doi: 10.1002/hep.23380 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23380</ArticleId><ArticleId IdType="pubmed">20041405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>